On October 17, 2017, KEI sent a letter to the NIH regarding the failure of the University of Pennsylvania to disclose federal funding of five patented inventions for CAR T.
Today (October 18, 2017), we received this statement from the University:
“We have reviewed the letter and have confirmed that each of these patents was reported to the government as having NIH funding.
There is an update on this issue, here: /node/2882, noting that the University filed a correction to each of the five patents, reporting federal funding of the inventions.
On October 13, 2017, KEI submitted comments to the WHO regarding the Draft Concept Note towards the WHO’s 13th General Programme of Work. The Draft Concept Note is available here: http://www.who.int/about/draft-concept-note_13th-programme-work.pdf
The text of KEI’s comments follow below, and a PDF is available here.
Friday, 13 October 2017
Dear Dr. Tedros,
The biologic drug, Humira (adalimumab) is currently the best selling drug in the world, with revenues of more than $16 billion in 2016, and $4.7 billion in the 2nd quarter of 2017 ($52 million per day). 
Continue Reading
At 17:00 on Friday, 6 October 2017, the facilitators for WIPO’s informal discussions on Matters Concerning the Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore circulated a draft decision on the future mandate of the committee. This text is a revised version of the document circulated at 13:30 on Thursday, 5 October 2017. The WIPO General Assembly is continuing its informals on the future of the IGC mandate between 15:00 to 16:30 on Monday, 9 October 2017 (according to the Daily Journal published by the WIPO Secretariat).
On Friday, 6 October 2017, Knowledge Ecology International delivered the following statement at the 2nd session of the Marrakesh Treaty Assembly in Geneva.
Statement of Knowledge Ecology International – Marrakesh Treaty Assembly
Agenda item 27 – Marrakesh Treaty to Facilitate Access to Published Works for Persons Who Are Blind, Visually Impaired or Otherwise Print Disabled (MVT)
6 October 2017
Thank you Chair,
On Wednesday, 4 October 2017, Brazil delivered this perspicacious statement on the WIPO Development Agenda.
Thank you, Mr. Chairman,
As everyone knows, the CDIP follows in the footsteps of the Development Agenda. In this regard, Brazil believes the implementation of the 45 recommendations is essential for this organization to be fully representative. Underlying the DA is the principle that a fair remuneration for the creations of human spirit goes together with the imperative of ensuring the right to health, culture, knowledge, information and education.
Continue Reading
On Wednesday, 4 October 2017, Chile delivered the following statement on the Report on The Standing Committee on the Law of Patents (SCP) at the WIPO General Assembly.
Gracias Sr. Presidente.
Quisiéramos felicitar el trabajo que el Comité de Patentes está llevando en temas diversos y balanceados, que han permitido su funcionamiento a lo largo de estos últimos años, privilegiando el diálogo técnico y experto sobre los diferentes puntos de la agenda.
On Wednesday, 4 October 2017, Knowledge Ecology International (KEI) delivered the following statement at the WIPO General Assembly during discussions on the Report of the Standing Committee on the Law of Patents (SCP).
WIPO General Assembly 2017 – Statement of KEI on the Report on the Standing Committee on the Law of Patents (SCP)
4 October 2017
Agenda item: 14. Report on the Standing Committee on the Law of Patents (SCP)
KEI Recommendations on the work of the SCCR on a treaty for broadcasting organizations
Prepared for WIPO General Assembly
October 4, 2017
KEI recommends taking the broadcasting treaty off the agenda of the SCCR, until (1) the proponents of the treaty can explain what they expect the treaty will do, in practical terms, (2) how the treaty will impact copyright owners and persons who want access to information distributed by broadcasters, and (3) if there is a realistic expectation of agreement on the substance of the treaty.